Get Your Personalized Supplement StackSupplement Stack Quiz

Echinacea Pallida Root Extract

Also known as: Echinacea pallida root extract, Pale purple coneflower, Echinacea pallida

Overview

Echinacea pallida root extract is derived from the roots of the pale purple coneflower, a plant native to North America. It is primarily utilized as an herbal remedy for the prevention and treatment of upper respiratory tract infections (URTIs), including the common cold. The extract contains various bioactive compounds such as alkamides, caffeic acid derivatives, and polysaccharides, which are believed to modulate immune function. While research on Echinacea species is extensive, much of the high-quality clinical data focuses on other species like Echinacea purpurea and Echinacea angustifolia. Specific, robust evidence for Echinacea pallida root extract alone is limited, often being grouped within broader Echinacea studies. The overall evidence base includes randomized controlled trials, systematic reviews, and meta-analyses, but results can vary significantly due to differences in species, plant parts used, extraction methods, and study designs.

Benefits

The most substantial evidence for benefits in URTI prevention and treatment comes from studies on *Echinacea purpurea* and *Echinacea angustifolia* extracts, showing modest reductions in the incidence and duration of URTIs. For instance, a 2025 meta-analysis on *Echinacea purpurea* found significant reductions in URTI duration, incidence, and antibiotic use, though with a slight increase in mild adverse events. A 2007 meta-analysis also suggested that echinacea extracts generally may reduce the incidence and duration of common colds. However, evidence specifically for *Echinacea pallida* root extract is scarce and inconclusive. A 1998 RCT involving *Echinacea angustifolia* and *Echinacea purpurea* root extracts did not find a significant prophylactic effect on URTI incidence, although a small effect could not be entirely ruled out. Therefore, while other *Echinacea* species show some promise for URTI, the specific benefits of *Echinacea pallida* root extract are not well-supported by dedicated high-quality research.

How it works

The proposed mechanisms of action for Echinacea species, including *Echinacea pallida*, involve immunomodulation. This is thought to occur through the stimulation of immune cells such as macrophages and natural killer cells, as well as the promotion of cytokine production. Bioactive compounds like alkamides, present in the extract, may interact with cannabinoid receptors, thereby influencing immune responses. The bioavailability of these compounds can vary depending on the extract type, with ethanolic extracts commonly used and believed to preserve active constituents. However, no direct molecular targets or specific mechanisms unique to *Echinacea pallida* root extract have been definitively identified or confirmed in clinical studies.

Side effects

Echinacea pallida root extract is generally considered safe, with mild side effects reported in a minority of users. These can include gastrointestinal discomfort, such as nausea or stomach upset, and skin rashes. A meta-analysis on *Echinacea purpurea* extracts noted a moderate increase in mild adverse events, with a relative risk of 1.38 compared to placebo. Rare allergic reactions are possible, particularly in individuals with known allergies to plants in the Asteraceae family (e.g., ragweed, marigolds, daisies). While no significant drug interactions or contraindications are extensively documented for *Echinacea pallida*, caution is advised for individuals with autoimmune diseases due to the potential immunostimulatory effects of Echinacea. It is always recommended to consult a healthcare professional before starting any new supplement, especially if you have pre-existing health conditions or are taking other medications.

Dosage

Specific dosing guidelines for *Echinacea pallida* root extract are not well-established due to the limited amount of dedicated research. In one 1998 randomized controlled trial, participants received 50 drops (approximately 1 mL) of a 1:11 ethanolic root extract twice daily for 12 weeks. For other *Echinacea* species, such as *Echinacea purpurea*, typical doses range from 300 to 500 mg of standardized extract, taken 2-3 times daily during acute episodes of upper respiratory tract infections. However, these dosages may not be directly applicable to *Echinacea pallida* root extract. Optimal dosing, formulation, and duration of use for *Echinacea pallida* require further dedicated research to provide clear and evidence-based recommendations. Users should follow product-specific instructions or consult a healthcare provider.

FAQs

Is Echinacea pallida root extract effective for cold prevention?

Current evidence is insufficient to confirm a significant preventive effect specifically for *Echinacea pallida* root extract. Most positive findings relate to other *Echinacea* species.

Are there safety concerns with Echinacea pallida root extract?

It is generally considered safe with mild side effects like gastrointestinal upset or rash. Rare allergic reactions can occur, especially in individuals sensitive to Asteraceae plants.

How soon do benefits appear when taking Echinacea pallida root extract?

If effective, benefits for URTI symptoms typically manifest within days to weeks of consistent use during an acute illness, similar to other *Echinacea* species.

Can Echinacea pallida root extract be used long-term?

Long-term safety data for *Echinacea pallida* root extract are limited. Most studies focus on short-term use during illness, so long-term use is not well-supported by research.

Research Sources

http://triggered.edina.clockss.org/ServeContent?issn=1063-3987&volume=7&issue=6&spage=541 – This 1998 randomized controlled trial investigated the prophylactic effect of *Echinacea angustifolia* and *Echinacea purpurea* root extracts on URTI incidence over 12 weeks. It found no significant prophylactic effect, though a small risk reduction could not be excluded. The study was high-quality but did not specifically include *Echinacea pallida*.
https://pubmed.ncbi.nlm.nih.gov/40311928/ – This 2025 meta-analysis of nine RCTs focused on *Echinacea purpurea* extracts. It found significant reductions in URTI duration, incidence, and antibiotic use, but also noted a moderate increase in mild adverse events. This high-quality meta-analysis provides strong evidence for *E. purpurea* but not *E. pallida*.
https://pmc.ncbi.nlm.nih.gov/articles/PMC7106401/ – This 2007 meta-analysis of 14 trials suggested that *Echinacea* extracts generally reduce the incidence and duration of the common cold, with some evidence for both prevention and treatment. The study was of moderate quality but included mixed *Echinacea* species, making specific conclusions about *E. pallida* difficult.